Cargando…
Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence
Comorbid primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) represent a unique disease phenotype with a different risk profile than PSC or IBD alone. While the pathogenetic mechanisms behind both diseases remain unclear, recent studies have targeted several immune-mediated pat...
Autores principales: | Mertz, Andrew, Nguyen, Nhu An, Katsanos, Konstantinos H., Kwok, Ryan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394256/ https://www.ncbi.nlm.nih.gov/pubmed/30837784 http://dx.doi.org/10.20524/aog.2019.0344 |
Ejemplares similares
-
Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Fousekis, Fotios S., et al.
Publicado: (2019) -
Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children
por: Yoon, Jisun, et al.
Publicado: (2015) -
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review
por: Da Cunha, Teresa, et al.
Publicado: (2022) -
Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
por: Kim, You Sun, et al.
Publicado: (2023) -
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
por: Lynch, Kate D., et al.
Publicado: (2020)